Can B Corp (NASC)
About Can B Corp
NASCENT PHARMA HOLDINGS
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2023
- $2.2M
- Net income
- -$9.7M
- Total assets
- $10.1M
Source: SEC EDGAR · updated Jun 8, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Can B Corp (NASC) Stock Price
- Reported a net loss of $9.7M in FY2023.
- Trading 75% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Can B Corp.
Write a review
Can B Corp: frequently asked questions
Is Can B Corp an American company?
Can B Corp is a US-based company headquartered in Hicksville, New York, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Can B Corp headquartered?
Can B Corp is headquartered in Hicksville, New York, United States.
Is Can B Corp publicly traded?
Yes — Can B Corp is a publicly traded company. Its stock trades under the ticker symbol NASC on the OTC.
What does Can B Corp do?
Can B Corp is an American Pharmaceuticals company in the Health & Beauty sector.
